GAITHERSBURG: a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in
Tag "Novavax"


NEW DELHI: As India ranked 10th in the global infection list, overtaking Iran, which was an early hotspot of coronavirus, India’s top medical body has said the human trials of

SYDNEY: US-based biotechnology company Novavax has started enrolling participants in Australia for a clinical trial of its coronavirus vaccine candidate, NVX-CoV2373. Preliminary immunogenicity and safety results from the Phase 1 portion